The following scan is of a young woman on oral contraceptives. The most likely diagnosis is:

Correct Answer: A. Hepatic adenoma

Hepatic adenoma is a benign hepatic tumor with a well-established association with oral contraceptive use, particularly with prolonged exposure and higher estrogen doses. The risk increases significantly with duration of OCP use (>5 years) and is dose-dependent. On imaging, hepatic adenomas typically appear as well-circumscribed, solitary lesions with homogeneous enhancement in the arterial phase followed by washout in the portal venous phase. The key discriminating feature in this case is the clinical context of a young woman on OCPs combined with imaging findings of a solitary, well-defined lesion. Unlike hepatocellular carcinoma (which occurs in cirrhotic livers with background parenchymal disease), adenomas arise in non-cirrhotic livers. The lesion's benign imaging characteristics—lack of rim enhancement, absence of satellite nodules, and homogeneous appearance—exclude malignancy. In Indian clinical practice, OCP-related adenomas are increasingly recognized as awareness of hormonal contraception grows. The management approach is conservative observation with imaging surveillance, though surgical resection may be considered if the lesion is >5 cm or shows growth, given the small risk of rupture and hemorrhage. This diagnosis exemplifies the importance of integrating clinical history (medication use) with radiological findings in differential diagnosis.

Why the other options are wrong

B. Hepatocellular carcinoma — HCC typically arises in a background of cirrhosis or chronic liver disease (HBsAg+, anti-HCV+, alcoholic cirrhosis), which is absent in this young woman on OCPs. HCC shows characteristic imaging features: arterial phase hyperenhancement with washout in portal venous/delayed phases, often with a rim of enhancement. The clinical context—young, non-cirrhotic patient—makes HCC highly unlikely. This is a classic NBE trap pairing 'liver lesion' with 'malignancy' to test whether students consider clinical context. C. Metastatic infiltrates — Metastases typically present as multiple lesions (though solitary mets are possible) and occur in patients with known primary malignancy elsewhere. The imaging pattern of metastases varies by primary tumor type but often shows heterogeneous enhancement and lacks the homogeneous, well-circumscribed appearance of adenoma. The absence of systemic symptoms, normal liver function, and lack of primary tumor history in a young woman on OCPs makes metastatic disease implausible. This option tests whether students reflexively consider malignancy without clinical correlation. D. Hemangioma — Hemangiomas are the most common benign liver lesions overall but show a pathognomonic imaging pattern: peripheral nodular enhancement in the arterial phase with progressive centripetal fill-in on delayed images ('puddling'). They are typically small (<2 cm), asymptomatic, and incidental. Hemangiomas are not associated with OCP use and lack the homogeneous arterial enhancement pattern of adenoma. The clinical context of OCP use strongly favors adenoma over hemangioma, making this a distractor for students who know hemangioma is benign but forget the OCP-adenoma association.

High-Yield Facts

Mnemonics

OCP-ADENOMA Association Oral Contraceptives → Adenoma (benign, Arterial enhancement, Arises in non-cirrhotic liver). Use when you see 'young woman + OCP + solitary liver lesion.' Benign Liver Lesion Imaging (HAHA) Hemangioma = peripheral nodular enhancement + centripetal fill-in (puddling); Adenoma = homogeneous arterial enhancement + washout. Helps distinguish two common benign lesions.

NBE Trap

NBE pairs 'liver lesion' with 'malignancy' (HCC, metastases) to test whether students reflexively choose cancer without integrating clinical context (young, non-cirrhotic, on OCPs). The trap rewards students who correlate medication history with imaging findings.

Clinical Pearl

In Indian clinical practice, as OCP use increases among urban women, hepatic adenoma is increasingly recognized on incidental imaging. Key counseling point: reassure the patient that adenoma is benign and does not require immediate surgery unless >5 cm or showing growth; however, OCPs should be discontinued to prevent further growth, and imaging surveillance (ultrasound or CT every 6–12 months) is recommended.

_Reference: Robbins Ch. 19 (Liver and Biliary Tract); Harrison Ch. 297 (Tumors of the Liver)_